WACC over the last 12 months

Healthcare & Pharmaceuticals Apr 2024 May 2024 Jun 2024 Jul 2024 Aug 2024 Sep 2024 Oct 2024 Nov 2024 Dec 2024 Jan 2025 Feb 2025 Mar 2025 WACC bandwidth WACC average 6,4% 6,7% 6,3% 6,4% 6,2% 6,2% 6,2% 6,1% 6,2% 6,3% 6,6% 6,6%

WACC summary

Healthcare & Pharmaceuticals, March 2025 Beta 0,9 Market risk premium incl. Small Cap Premium 6,5% – 8,0% Cost of equity 6,3% – 7,6% Cost of debt 1,8% Risk free rate 0,70% Credit Spread 1,3% Tax Shield 0,3% Risk free rate 0,70% Cost of equity Cost of debt 6,0% – 7,2% WACC 91,8% Equity ratio 8,2% Debt ratio
Dr. Marc Schmidli, CFA

Questions?

Dr. Marc Schmidli, CFA

PwC | Partner | Deals and Valuation Leader
Office: +41 58 792 1564 | Mobile: +41 79 211 7786
PricewaterhouseCoopers AG
Birchstrasse 160 | Postfach | CH-8050 Zürich
http://www.pwc.ch

Thomas Schneller, CFA

Questions?

Thomas Schneller, CFA

PwC | Director | Deals | Valuation & Modelling
Office: +41 58 792 1519 | Mobile: +41 79 608 4445 | Main: +41 58 792 4400
PricewaterhouseCoopers AG
Birchstrasse 160 | 8050 Zürich | Switzerland
http://www.pwc.ch